Endocrine Procedure Note:
Procedure Name:
Fine-needle aspiration of thyroid nodule
Indication:
Patient presents with a 2.5 cm solitary, firm, non-tender thyroid nodule identified on routine physical examination and confirmed via ultrasound. Ultrasound characteristics (hypoechoic, irregular margins, microcalcifications) suggest potential malignancy, necessitating further investigation for definitive diagnosis.
Pre-procedure Evaluation:
Physical examination revealed a palpable, firm nodule in the right lobe of the thyroid. Patient counselled extensively on the procedure, potential risks (bleeding, infection, pain), and benefits. Informed consent obtained verbally and in writing, adhering to South African public sector protocol for elective procedures. Relevant labs: TSH within normal limits (1.8 mIU/L), normal coagulation profile. Previous ultrasound report reviewed, confirming nodule characteristics.
Procedure Description:
Performed in an outpatient clinic setting. The patient was positioned supine with neck extended. Skin prepped with chlorhexidine solution. Local anaesthesia (1% Lidocaine) infiltrated subcutaneously. Under real-time ultrasound guidance, a 25-gauge needle was advanced into the thyroid nodule. Multiple passes were made to obtain adequate cellular material. Smears were immediately prepared on glass slides and fixed in alcohol for cytological examination. Materials used: 25-gauge needle, 10cc syringe, sterile drapes, chlorhexidine, Lidocaine. No sedation administered.
Findings:
Ultrasound guidance confirmed accurate needle placement within the nodule. No immediate complications observed during the procedure (e.g., haematoma, significant pain). Adequate cellularity observed on rapid on-site evaluation by the pathologist. Patient tolerated the procedure well.
Post-procedure Plan:
Patient instructed to apply light pressure to the site for 10 minutes and to avoid strenuous activity for 24 hours. Advised on signs of potential complications (swelling, redness, increasing pain) and when to seek medical attention. Pain management with over-the-counter paracetamol as needed. Cytology results anticipated in 7-10 working days. Follow-up appointment scheduled for 1 November 2024 to discuss results and further management, which may include surgical referral depending on findings. All instructions are feasible within the South African public healthcare context.
Endocrine Procedure Note:
Procedure Name:
[specify procedure performed e.g. fine-needle aspiration, dynamic testing] (Only include if explicitly mentioned in transcript or context, else omit section entirely.)
Indication:
[document reason for procedure and clinical context] (Only include if explicitly mentioned in transcript or context, else omit section entirely.)
Pre-procedure Evaluation:
[detail physical exam, consent process, relevant labs or imaging] (Only include if explicitly mentioned in transcript or context, else omit section entirely. Ensure reference to South African standards for informed consent and public/private sector protocol where applicable.)
Procedure Description:
[document technical steps, materials used, sedation/anaesthesia details if applicable. Include whether performed in outpatient, clinic, or hospital setting] (Only include if explicitly mentioned in transcript or context, else omit section entirely.)
Findings:
[describe intra-procedural findings or notable observations] (Only include if explicitly mentioned in transcript or context, else omit section entirely.)
Post-procedure Plan:
[include any monitoring, patient instructions, complications, referrals, follow-up testing or ongoing care. Ensure instructions are feasible within the South African public/private healthcare context] (Only include if explicitly mentioned in transcript or context, else omit section entirely.)
(Never come up with your own patient details, assessment, plan, interventions, evaluation, and plan for continuing care - use only the transcript, contextual notes or clinical note as a reference for the information included in your note. If any information related to a placeholder has not been explicitly mentioned in the transcript, contextual notes or clinical note, you must not state the information has not been explicitly mentioned in your output, just leave the relevant placeholder or omit the placeholder completely.)